Turnover
≈ €120,000 estimated
The micro format states no turnover.
GYNESIA
Lifetime
2 annual accounts with figures on one time axispeak €39,288 (2025)
€39,288▲ 149%
peak €29,912 (2025)
€29,912▲ 188%
peak €45,282 (2025)
€45,282▲ 195%
€34,429▲ 43.4%
Board1 name since 2023
1 director
Documentsfilings and deeds
09-06-202652 days before the deadline
2025micro format
Gross margin from €15,808 to €39,288Result from €10,370 to €29,912Equity from €15,370 to €45,282Debts from €24,016 to €34,429Cash from €23,092 to €66,358
Key points
from the 2025 annual accountsLiquidity
2.32 was 1.64 in 2024
Short-term debts rose from €24,016 to €34,429.
Starting capital
€5,000 200 shares
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 39,326 companies had the same profile as GYNESIA has now. Each dot stands for 99 companies, two years later.
95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,326 companies, not a prediction for GYNESIA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered office moved within Anderlecht
New registered office: rue Delwart 173 à 1070 Anderlecht · Previous registered office: boulevard Paepsem 20, 1070 Anderlecht · Board meeting of 30-12-2025 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:1002028311
Incorporation
Founding capital of €5,000, 200 shares · Founder: · Appointment: (statutory director) · published on 09-11-2023 · Gazette deed
First establishment
Delwartstraat 173, Anderlecht
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| GYNESIA Anderlecht | €79,711 | €39,288 | 56.8% | - |
| Medesi Hasselt | €77,513 | €41,718 | 94.1% | - |
| Docteur Pierre DELVOYE Esneux | €80,202 | €40,495 | 5.1% | - |
| Camille SCHNACKERS Verviers | €84,968 | €37,842 | 87.3% | - |
| Lien Deltour Huisarts Ghent | €69,823 | €41,187 | 89.7% | - |
| Dokter Christophe Cantoro Ghent | €83,261 | €43,755 | 73.7% | - |
| SPMM SRL Anderlecht | €113,377 | €38,075 | 43.3% | - |
These companies have the same main activity as GYNESIA: general medical practice (NACE 86210). They are comparable in size and age: total assets between €69,800 and €113,000, founded in 2023.
Official details
Source: KBO- Status
- Active since 07-11-2023Normal situation
- Activity
- General medical practiceNACE 86210
- Establishment unit
- 2.351.776.7771070 Anderlecht, since 07-11-2023
- Financial year end
- 31 December
- Peppol
- Reachable since 06-01-2026
Annual accounts 2025
- €79,711▲ 102%
- Filing
- Filed on 09-06-2026, 52 days before the end of the filing period
Insights on GYNESIA
GYNESIA has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €45,282 and a net result of €29,912.
Its solvency ranks better than 45% of 21,322 sector peers (NACE 86, financial year 2025).
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about GYNESIA
- What is the company number of GYNESIA?
- The company number of GYNESIA is 1002.028.311. The VAT number is the same number with BE in front: BE 1002.028.311.
- Where is GYNESIA based?
- The registered office is at Delwartstraat 173, 1070 Anderlecht.Company details
- What does GYNESIA do?
- According to the KBO register, the main activity is general medical practice (NACE 86210).
- What is the legal form of GYNESIA?
- GYNESIA is a private limited company (BV).
- When was GYNESIA founded?
- GYNESIA was founded on 07-11-2023.
- Is GYNESIA still active?
- Yes, GYNESIA is an active enterprise in the KBO register.
- What is the turnover of GYNESIA?
- The turnover in financial year 2025 is ≈ €120,000. This figure is estimated from the gross margin of €39,288 and 47 comparable companies (NACE 86). It probably lies between €87,000 and €170,000.Financials
- Is GYNESIA profitable?
- In financial year 2025, GYNESIA made a profit of €29,912.
- Where can I find the annual accounts of GYNESIA?
- GYNESIA filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of GYNESIA due?
- GYNESIA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.